Form 4 holding
VP Chief Financial Officer
CUMBERLAND PHARMACEUTICALS INC
- Security class
- Options (right to buy)
- Shares / value
- 18,250
- Estimated value
- $78,843
- Report date
- 18 Mar 2026
- Price
- $5.17
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount